Bayshore Pharmaceuticals, LLC recalls Bayshore Pharmaceuticals, LLC — Metformin Hydrochloride Extended-Release Tablets USP, 500 mg & 750 mg
- Recall date
- August 20, 2020
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Bayshore Pharmaceuticals, LLC, Bayshore Pharmaceuticals, LLC
Why it was recalled
Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity — Impurity
What was recalled
Metformin Hydrochloride Extended-Release Tablets USP, 500 mg & 750 mg
Read the official recall notice →
Get recall alerts
Free email alert whenever Bayshore Pharmaceuticals, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Bayshore Pharmaceuticals, LLC, Bayshore Pharmaceuticals, LLC